INSIGHTS ON DRUG DEVELOPMENT

• De-Risking Drug Development: Informatics-Supported Solid Form Selection

  Learn how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.

• Bioanalytical Quantification Of A Biotherapeutic Peptide

  Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.

• Improving Next-Generation Sequencing Workflows With Droplet Digital PCR

  Optimize NGS workflows by using digital PCR for absolute quantification. Improve library quality, reduce bias, and gain sensitive validation for rare variants in complex genomic samples.

• Sustainable Manufacturing Through Automation, Flow Chemistry, And Biocataysis

   Learn how modeling, high-throughput tools, and advanced analytics enable safer, more efficient routes and support scalable solutions for complex chemical and enzymatic processes.

• Thunderstruck By Antibody-Drug Conjugates

  3/18/2025

  Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.

• Cell Cycle Mapping In Tumors With Advanced Technologies

  9/2/2025

  Discover how spatial profiling and advanced imaging tools are transforming drug discovery, featuring Wayne Stallaert’s lab’s work on cell cycle mapping and biomarker insights in cancer research.

• Aggregation In Antibody-Drug Conjugates: Causes And Mitigation

  9/1/2025

  Discover how early intervention in ADC development can streamline clinical progress, ensure stability and safety, and accelerate commercialization with expert guidance.

• Inside Asymchem's Advanced R&D Capabilities In The UK

  2/12/2026

  Advanced experimentation, unified workflows, and continuous manufacturing are accelerating small‑molecule development, improving insight and creating more efficient paths from discovery to scale.

• The Organ-Chip Portfolio

  10/15/2024

  Watch to learn about an organ-chip that has been designed to reduce drug absorption while improving biological modeling to provide researchers with enhanced accuracy in forecasting human drug response.